Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (10)

2022

  1. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

    Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871

2019

  1. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

    Breast Cancer Research, Vol. 21, Núm. 1

2018

  1. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

    Journal of Translational Medicine, Vol. 16, Núm. 1

2017

  1. Significance of EGFR expression in circulating tumor cells

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 285-296

2016

  1. Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection

    PLoS ONE, Vol. 11, Núm. 2

2013

  1. Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report

    Oncology Letters, Vol. 5, Núm. 4, pp. 1382-1384

2006

  1. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor

    Annals of Oncology, Vol. 17, Núm. 11, pp. 1644-1649

2002

  1. A propósito de un caso: Linfoma anaplásico en un paciente con lupus eritematoso sistémico

    Oncologia, Vol. 25, Núm. 6, pp. 64-67

1989

  1. Global and free of disease survival in breast cancer. Influential factors

    Oncologia, Vol. 12, Núm. 2, pp. 83-92

1985

  1. Prolactin and human cancer of the breast. I. Levels of correlation

    Revista española de oncología, Vol. 32, Núm. 3, pp. 439-458